Trial record 1 of 1 for:    NCT01233505
Previous Study | Return to List | Next Study

Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors

This study has been terminated.
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT01233505
First received: November 2, 2010
Last updated: April 1, 2014
Last verified: October 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: No date given
  Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)